Will Johnson & Johnson (JNJ) Q2 Innovation Medicine revenue be above __?
1 signal across 1 market · $1,121 tracked · resolves Jul 15, 2026
This event tracks a Polymarket prediction market on Johnson & Johnson's Q2 Innovative Medicine revenue, specifically whether the reported figure comes in above $16.8B. Traders are pricing the outcome ahead of JNJ's official earnings materials, with recent PolySpotter alerts showing sharp buying on the No side.
Markets (1)
Top trades across all markets
Top wallets in this event
- 0xa14bf6…05e4$1,121 · 1 market · 1 alert · 74% wins
FAQs
What is the JNJ Q2 Innovative Medicine revenue prediction market about?
This Polymarket event asks whether Johnson & Johnson's Innovative Medicine revenue for the second fiscal quarter will be above $16.8B, based on the figure reported in the company's official earnings materials.
What do the current odds represent?
The odds reflect the market-implied probability that JNJ reports Q2 Innovative Medicine revenue above $16.8B. Because this is a prediction market, prices can move as traders react to analyst expectations, company news, and broader healthcare-sector signals.
What is the smart money doing on this event?
PolySpotter has tracked $1,121 in smart money activity across this event, with a recent alert indicating linked sharp buying on the No side. That suggests at least one monitored sharp wallet or linked group has been positioning against revenue exceeding $16.8B.
When will this JNJ revenue market resolve?
The market is expected to resolve after Johnson & Johnson releases its official Q2 earnings materials, with a listed resolution date of July 15, 2026. The reported Innovative Medicine revenue figure in those materials determines the outcome.